Exact Mass: 347.0946238
Exact Mass Matches: 347.0946238
Found 447 metabolites which its exact mass value is equals to given mass value 347.0946238,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Hydroxysanguinarine
C20H13NO5 (347.07936880000005)
Hydroxysanguinarine is a benzophenanthridine alkaloid. Hydroxysanguinarine is a natural product found in Fumaria indica, Fumaria parviflora, and other organisms with data available.
Adenosine monophosphate
Adenosine monophosphate, also known as adenylic acid or amp, is a member of the class of compounds known as purine ribonucleoside monophosphates. Purine ribonucleoside monophosphates are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Adenosine monophosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Adenosine monophosphate can be found in a number of food items such as kiwi, taro, alaska wild rhubarb, and skunk currant, which makes adenosine monophosphate a potential biomarker for the consumption of these food products. Adenosine monophosphate can be found primarily in most biofluids, including blood, feces, cerebrospinal fluid (CSF), and urine, as well as throughout all human tissues. Adenosine monophosphate exists in all living species, ranging from bacteria to humans. In humans, adenosine monophosphate is involved in several metabolic pathways, some of which include josamycin action pathway, methacycline action pathway, nevirapine action pathway, and aspartate metabolism. Adenosine monophosphate is also involved in several metabolic disorders, some of which include hyperornithinemia-hyperammonemia-homocitrullinuria [hhh-syndrome], molybdenum cofactor deficiency, xanthinuria type I, and mitochondrial DNA depletion syndrome. Adenosine monophosphate is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalanc. Adenosine monophosphate, also known as 5-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a Bitter Blocker additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem sweeter. This potentially makes lower calorie food products more palatable. [Spectral] AMP (exact mass = 347.06308) and Guanine (exact mass = 151.04941) and 3,4-Dihydroxy-L-phenylalanine (exact mass = 197.06881) and Glutathione disulfide (exact mass = 612.15196) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] AMP (exact mass = 347.06308) and Glutathione disulfide (exact mass = 612.15196) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] AMP (exact mass = 347.06308) and Adenine (exact mass = 135.0545) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. Adenosine monophosphate. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=67583-85-1 (retrieved 2024-07-01) (CAS RN: 61-19-8). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction.
2'-Deoxyguanosine 5'-monophosphate
C10H14N5O7P (347.06308240000004)
2-Deoxyguanosine 5-monophosphate, also known as deoxyguanylic acid or 2-deoxy-GMP, belongs to the class of organic compounds known as purine 2-deoxyribonucleoside monophosphates. These are purine nucleotides with monophosphate group linked to the ribose moiety lacking a hydroxyl group at position 2. 2-Deoxyguanosine 5-monophosphate is a purine 2-deoxyribonucleoside 5-monophosphate having guanine as the nucleobase. It exists in all living species, ranging from bacteria to humans. Within humans, 2-deoxyguanosine 5-monophosphate participates in a number of enzymatic reactions. In particular, 2-deoxyguanosine 5-monophosphate can be converted into dGDP which is mediated by the enzyme guanylate kinase. In addition, 2-deoxyguanosine 5-monophosphate can be converted into deoxyguanosine through its interaction with the enzyme cytosolic purine 5-nucleotidase. In humans, 2-deoxyguanosine 5-monophosphate is involved in the metabolic disorder called the gout or kelley-seegmiller syndrome pathway. 2-Deoxyguanosine 5-monophosphate is a derivative of the common nucleic acid GTP, or guanosine triphosphate, in which the -OH (hydroxyl) group on the 2 carbon on the nucleotides pentose has been removed (hence the deoxy- part of the name). Additionally, the diphosphate of the name indicates that two of the phosphoryl groups of GTP have been removed, most likely by hydrolysis . [HMDB] Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Cephalexin
C16H17N3O4S (347.09397220000005)
Cephalexin is only found in individuals that have used or taken this drug. It is a semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of cephaloridine or cephalothin, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. [PubChem]Cephalexin, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cephalexin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; INTERNAL_ID 1046
3'-AMP
C10H14N5O7P (347.06308240000004)
Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2-, 3-, or 5-position. 3-AMP has been identified in the human placenta (PMID: 32033212). Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2-, 3-, or 5-position. [HMDB] Acquisition and generation of the data is financially supported in part by CREST/JST. CONFIDENCE standard compound; ML_ID 11
Adenosine 2'-phosphate
C10H14N5O7P (347.06308240000004)
Adenosine 2-phosphate is converted enzymatically from adenosine 2,3-cyclic phosphate via the enzyme 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). In the brain, this enzyme acts on 2,3-cyclic AMP more rapidly than on the UMP or CMP derivatives. In the liver, this enzyme acts on 2,3-cyclic CMP more rapidly than on the purine derivatives; it also hydrolyses the corresponding 3,5-cyclic phosphates, more slowly. This latter enzyme has been called cyclic-CMP phosphodiesterase. (KEGG). This enzyme belongs to the family of hydrolases, specifically those acting on phosphoric diester bonds. The systematic name of this enzyme class is nucleoside-2,3-cyclic-phosphate 2-nucleotidohydrolase. (Wikipedia). Adenosine 2-phosphate is converted enzymatically from adenosine 2,3-cyclic phosphate via the enzyme 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). In the brain, this enzyme acts on 2,3-cyclic AMP more rapidly than on the UMP or CMP derivatives. In the liver, this enzyme acts on 2,3-cyclic CMP more rapidly than on the purine derivatives; it also hydrolyses the corresponding 3,5-cyclic phosphates, more slowly. This latter enzyme has been called cyclic-CMP phosphodiesterase. (KEGG) Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2]. Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2]. Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2].
EVOXINE
C18H21NO6 (347.13688060000004)
7-alpha-D-Ribosyladenine 5-phosphate
C10H14N5O7P (347.06308240000004)
2-hydroxy-dAMP
C10H14N5O7P (347.06308240000004)
2-hydroxy-damp is a substrate for: 7,8-dihydro-8-oxoguanine triphosphatase.
Dide-O-methylsimmondsin
Dide-O-methylsimmondsin is found in coffee and coffee products. Dide-O-methylsimmondsin is a constituent of jojoba meal. Constituent of jojoba meal. Di-demethylsimmondsin is found in coffee and coffee products, fats and oils, and nuts.
1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine
C21H17NO4 (347.11575220000003)
1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine is found in fruits. 1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). 1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine is found in herbs and spices and fruits.
5'-Hydroxypiroxicam
5-Hydroxypiroxicam is only found in individuals that have used or taken Piroxicam. 5-Hydroxypiroxicam is a metabolite of Piroxicam. 5-hydroxypiroxicam belongs to the family of Benzothiazines. These are organic compounds containing a benzene fused to a thiazine ring (a six-member ring with four carbon atoms, one nitrogen atom and one sulfur atom).
Embramine
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Embramine is an ethanolamine H1-antihistamine.
Vidarabine phosphate
C10H14N5O7P (347.06308240000004)
Adenosine monophosphate, also known as 5-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a Bitter Blocker additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem sweeter. This potentially makes lower calorie food products more palatable [HMDB] Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction.
3-Phosphoadenosine
C10H14N5O7P (347.06308240000004)
5-Aminofluorescein
C20H13NO5 (347.07936880000005)
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
2-(3,6,9-Trihydroxy-4-amino-9H-xanthene-9-yl)benzoic acid gamma-lactone
C20H13NO5 (347.07936880000005)
Zidovudine monophosphate
C10H14N5O7P (347.06308240000004)
Desmethylofloxacin
C17H18FN3O4 (347.12812800000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
6-(4-(Trifluoromethoxy)phenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine
C14H7F6N3O (347.04932840000004)
Nafamostat
D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D051056 - Complement Inactivating Agents COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Naproxcinod
C18H21NO6 (347.13688060000004)
Nizatidine sulfoxide
C12H21N5O3S2 (347.10857560000005)
(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile
C16H17N3O4S (347.09397220000005)
[(2R,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate
C10H14N5O7P (347.06308240000004)
Leonurine HCl
Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory. Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory.
2-carboxymethyl-5-hydroxy-7-phenyl-2H-benzo[de]isoquinoline-1,6-dione
C20H13NO5 (347.07936880000005)
Clanobutin
C18H18ClNO4 (347.09242980000005)
C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents
(+)-4-(6-methoxy-9-methyl-8-oxo-8,9-dihydro-[1,3]dioxolo[4,5-h]quinolin-7-yl)-2-methyl-butyric acid methyl ester|Pteleolin|Pteleoline
C18H21NO6 (347.13688060000004)
4-hydroxy-9-carboxynonenoic lactone mercapturic acid
C14H21NO7S (347.10386760000006)
(2S)-1-[(6,7-dimethoxyfuro[2,3-b]quinolin-4-yl)oxy]-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
1,6-Dioxo-5-hydroxy-7-phenyl-1,2-dihydro-6H-benzo[de]isoquinoline-2-acetic acid
C20H13NO5 (347.07936880000005)
Me glycoside,Me ester,N,1,2-tri-Ac-alpha-D-Pyranose-4-Amino-4-deoxyglucuronic acid
(-)-circumdatin H|(5bS)-2-methoxy-5b,6,7,8-tetrahydro-10H,16H-pyrrolo[2,1-c]quinazolino[3,2-a]benzodiazepine-10,16-dione|(S)-(-)-circumdatin H|(S)-2-methoxy-5b,6,7,8-tetrahydrobenzo[6,7]pyrrolo[2,1:3,4][1,4]diazepino[2,1-b]quinazoline-10,16-dione|circumdatin H
C20H17N3O3 (347.12698520000004)
Leonurine HCl
Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory. Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory.
Cefalexin
C16H17N3O4S (347.09397220000005)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3014
Kinetin riboside
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins relative retention time with respect to 9-anthracene Carboxylic Acid is 0.645 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.646 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.642 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.644 Kinetin riboside, a cytokinin analog, can induce apoptosis in cancer cells. It inhibits the proliferation of HCT-15 cells with an IC50 of 2.5 μM.
2-Deoxy-5-Guanylic Acid
C10H14N5O7P (347.06308240000004)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS relative retention time with respect to 9-anthracene Carboxylic Acid is 0.057 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.055
3-Adenylic acid
C10H14N5O7P (347.06308240000004)
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.055 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.056
Adenosine 5-monophosphate
C10H14N5O7P (347.06308240000004)
Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction.
2-Deoxyguanosine 5-monophosphate
C10H14N5O7P (347.06308240000004)
A purine 2-deoxyribonucleoside 5-monophosphate having guanine as the nucleobase.
2-Adenylic acid
C10H14N5O7P (347.06308240000004)
Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2]. Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2]. Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2].
Cephalexin
C16H17N3O4S (347.09397220000005)
A semisynthetic first-generation cephalosporin antibiotic having methyl and beta-(2R)-2-amino-2-phenylacetamido groups at the 3- and 7- of the cephem skeleton, respectively. It is effective against both Gram-negative and Gram-positive organisms, and is used for treatment of infections of the skin, respiratory tract and urinary tract. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
5-Adenylic acid
C10H14N5O7P (347.06308240000004)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites
Ala Gly Asn Ser
Ala Gly Ser Asn
Ala Asn Gly Ser
Ala Asn Ser Gly
Ala Ser Gly Asn
Ala Ser Asn Gly
Gly Ala Asn Ser
Gly Ala Ser Asn
Gly Gly Asn Thr
Gly Gly Gln Ser
Gly Gly Ser Gln
Gly Gly Thr Asn
Gly Asn Ala Ser
Gly Asn Gly Thr
Gly Asn Ser Ala
Gly Asn Thr Gly
Gly Gln Gly Ser
Gly Gln Ser Gly
Gly Ser Ala Asn
Gly Ser Gly Gln
Gly Ser Asn Ala
Gly Ser Gln Gly
Gly Thr Gly Asn
Gly Thr Asn Gly
Asn Ala Gly Ser
Asn Ala Ser Gly
Asn Gly Ala Ser
Asn Gly Gly Thr
Asn Gly Ser Ala
Asn Gly Thr Gly
Asn Ser Ala Gly
Asn Ser Gly Ala
Asn Thr Gly Gly
Gln Gly Gly Ser
Gln Gly Ser Gly
Gln Ser Gly Gly
Ser Ala Gly Asn
Ser Ala Asn Gly
Ser Gly Ala Asn
Ser Gly Gly Gln
Ser Gly Asn Ala
Ser Gly Gln Gly
Ser Asn Ala Gly
Ser Asn Gly Ala
Ser Gln Gly Gly
Thr Gly Gly Asn
Thr Gly Asn Gly
Thr Asn Gly Gly
1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine
C21H17NO4 (347.11575220000003)
Pyrido[2,3-b][1,6]naphthyridine, 7-[2-(acetyloxy)benzoyl]-6,7,8,9-tetrahydro- (9CI)
C20H17N3O3 (347.12698520000004)
3-[BENZYL-(TOLUENE-4-SULFONYL)-AMINO]-2-METHYL-PROPIONIC ACID
1-naphthyl-n-acetyl-beta-d-glucosaminide
C18H21NO6 (347.13688060000004)
5-Pyrimidinecarbonitrile, 4-amino-2-(2,5-dihydroxyphenyl)-6-(3-piperidinyl)-, (HCl salt)
Thiazolidine, 3-[(2,4-dimethylphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
Thiazolidine, 3-[(4-ethylphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
4-(Benzoylamino)-2,5-diethoxybenzenediazonium chloride
C17H18ClN3O3 (347.10366280000005)
diethyl 2-(trifluoromethoxy)phenylamino-n-methylenemalonate
C15H16F3NO5 (347.09805220000004)
Boc-(R)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
Boc-(S)-3-Amino-4-(4-trifluoromethyl-phenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
5-(N-(4-butylphenyl)sulfamoyl)-2-Methylbenzoic acid
5-(3-AMINO-5-OXO-2-PYRAZOLIN-1-YL)-2-PHENOXYBENZENESULFONIC ACID
Vidarabine phosphate
C10H14N5O7P (347.06308240000004)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D009676 - Noxae > D000963 - Antimetabolites Vidarabine phosphate (Ara-AMP), an antiviral agent, inhibits chronic HBV infection[1][2]. Vidarabine phosphate also against herpes simplex and varicella zoster viruses[3].
Boc-(R)-3-amino-4-(2-trifluoromethylphenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
3-(3,4-Dimethoxy-benzoylamino)-3-(4-fluoro-phenyl)-propionic acid
C18H18FNO5 (347.11689500000006)
4-(Benzyloxy)-5-bromo-2-(piperidin-1-yl)pyrimidine
6-tert-Butyl-4-methyl-2-[(4-chloro-2-nitrophenyl)azo]phenol
C17H18ClN3O3 (347.10366280000005)
Bicyclo[2.2.1]heptan-2-amine,N-[(4-chlorophenyl)phenylmethyl]-, hydrochloride (1:1)
1-ETHYNYL-4-((4-((4-NITROPHENYL)ETHYNYL)PHENYL)ETHYNYL)BENZENE
[2-(6-aminopurin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate
C10H14N5O7P (347.06308240000004)
ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE
2H-Pyrrol-2-one, 4-acetyl-1-(3-chloro-4-methylphenyl)-5-cyclohexyl-1,5-dihydro-3-hydroxy-
C19H22ClNO3 (347.1288132000001)
6-Chloro-2,3,4,5-tetrahydro-7,8-dimethoxy-1-(4-methoxyphenyl)-1H-3-benzazepine
C19H22ClNO3 (347.1288132000001)
Boc-(R)-3-amino-4-(2,4-dichlorophenyl)butyric acid
C15H19Cl2NO4 (347.06910740000006)
Boc-(R)-3-amino-4-(4-trifluoromethylphenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
Boc-(S)-3-Amino-4-(2-trifluoromethylphenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
Boc-(S)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid
C15H19Cl2NO4 (347.06910740000006)
Boc-(S)-3-Amino-4-(3-trifluoromethyl-phenyl)-butyric acid
C16H20F3NO4 (347.1344356000001)
2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-TOSYL-1H-PYRROLE
C17H22BNO4S (347.13625220000006)
Methanone, [4-(5-chloro-2-methylphenyl)-1-piperazinyl](3-ethyl-5-methyl-4-isoxazolyl)
C18H22ClN3O2 (347.14004620000003)
Methanone, [4-(3-chlorophenyl)-1-piperazinyl][3-methyl-5-(1-methylethyl)-4-isoxazolyl]
C18H22ClN3O2 (347.14004620000003)
6-AMINO-1-[3-(CYCLOPENTYLOXY)-4-METHOXYBENZYL]-2-THIOXO-2,3-DIHYDROPYRIMIDIN-4(1H)-ONE
C17H21N3O3S (347.13035560000003)
methyl 2,3-dihydro-2-(3-hydroxy-2-quinolyl)-1,3-dioxo-1H-indene-5-carboxylate
C20H13NO5 (347.07936880000005)
Sulbactam pivoxil
C14H21NO7S (347.10386760000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C2140 - Adjuvant > C183118 - Beta-lactamase Inhibitor
PFI-1
C16H17N3O4S (347.09397220000005)
4-[[(4-tert-butylphenyl)sulfonylamino]methyl]benzoic acid
1-benzyl-4-(2-methoxy-phenyl)-pyrrolidine-3-carboxylic acid hydrochloride
C19H22ClNO3 (347.1288132000001)
trans-1-Benzyl-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid
C19H22ClNO3 (347.1288132000001)
6-[5-({[2-(methylsulphonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-ol
C16H17N3O4S (347.09397220000005)
Boc-(R)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid
C15H19Cl2NO4 (347.06910740000006)
(2R,3S,4S,5R,6R)-2-(Acetoxymethyl)-6-aminotetrahydro-2H-pyran-3,4,5-triyl triacetate
ethyl 2-piperazine-4-(4-methoxy)phenyl thiazole-5-carboxylate
C17H21N3O3S (347.13035560000003)
7-(PHENYLACETAMIDO)-4-(TRIFLUOROMETHYL)COUMARIN
C18H12F3NO3 (347.07692380000003)
Boc-(S)-3-amino-4-(2,4-dichlorophenyl)butyric acid
C15H19Cl2NO4 (347.06910740000006)
N-[(2S)-3-Amino-2-hydroxypropyl]-N-[3-fluoro-4-(4-morpholinyl)phenyl]acetamide hydrochloride (1:1)
C15H23ClFN3O3 (347.14118900000005)
Benzyl 2-(methylsulfonyl)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate
C16H17N3O4S (347.09397220000005)
3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-TOSYL-1H-PYRROLE
C17H22BNO4S (347.13625220000006)
2-(1,4-Diazepan-1-yl)-1,3-benzothiazoletrifluoroacetic acid salt
C14H16F3N3O2S (347.09152720000003)
nalorphine hydrochloride ciii (250 mg)
C19H22ClNO3 (347.1288132000001)
naproxcinod
C18H21NO6 (347.13688060000004)
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D002317 - Cardiovascular Agents > D020030 - Nitric Oxide Donors C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor
L-779450
C20H14ClN3O (347.08253440000004)
L-779450 is a potent and selective B-Raf kinase inhibitor with a Kd of 2.4 nM.
Formycin-5-monophosphate
C10H14N5O7P (347.06308240000004)
D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D005573 - Formycins
2-Deoxyguanosine 3-(dihydrogen phosphate)
C10H14N5O7P (347.06308240000004)
6-(4-(Trifluoromethoxy)phenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine
C14H7F6N3O (347.04932840000004)
Circumdatin H
C20H17N3O3 (347.12698520000004)
An organic heteropentacyclic compound that is 5b,7,8,16-tetrahydro-6H,10H-pyrrolo[2,1-c]quinazolino[3,2-a][1,4]benzodiazepine substituted by a methoxy group at position 2 and oxo groups at positions 10 and 16 (the 5bS stereoisomer). An alkaloid isolated from the culture broth of Aspergillus ochraceus, it exhibits potent inhibitory activity towards mitochondrial NADH oxidase.
4-[[2-[(6-methyl-4-oxo-1H-pyrimidin-2-yl)thio]-1-oxoethyl]amino]benzoic acid ethyl ester
C16H17N3O4S (347.09397220000005)
2-[3-(3,4-Dimethoxyphenyl)pyrazolo[1,5-a]pyrimidin-5-yl]benzenol
C20H17N3O3 (347.12698520000004)
N-[1-(4-methyl-6-oxo-1-pyrimidinyl)-2-oxo-2-phenylethyl]benzamide
C20H17N3O3 (347.12698520000004)
N-[2-(3-oxo-4H-quinoxalin-2-yl)phenyl]-2-thiophenecarboxamide
C19H13N3O2S (347.07284380000004)
N2-(2-methoxyphenyl)-6-(3-methyl-2-benzofuranyl)-1,3,5-triazine-2,4-diamine
1-phenyl-N-[4-(pyridin-2-yl)-1,3-thiazol-2-yl]-1H-imidazole-5-carboxamide
C18H13N5OS (347.08407680000005)
(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
C18H21NO6 (347.13688060000004)
7-alpha-D-Ribofuranosyl-2-aminopurine-5-phosphate
C10H14N5O7P (347.06308240000004)
delta-(L-alpha-Aminoadipoyl)-L-cysteinyl-D-vinylglycine
Nafamostat
D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D051056 - Complement Inactivating Agents COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Embramine
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
BSPBio_000729
C18H21NO6 (347.13688060000004)
(2R,3R,4S,5R)-2-[6-(furan-2-ylmethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins
(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile
C16H17N3O4S (347.09397220000005)
8-hydroxy-dAMP
C10H14N5O7P (347.06308240000004)
A purine 2-deoxyribonucleoside 5-monophosphate that is that is dAMP in which the hydrogen at position 8 of the purine base has been replaced by a hydroxy group.
L-methionyl-3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine
[5-(7-amino-2H-pyrazolo[4,3-d]pyrimidin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
C10H14N5O7P (347.06308240000004)
L-Met-3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-OH
1,1-Ethenediamine, N-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-
C12H21N5O3S2 (347.10857560000005)
[9-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-iminopurin-3-yl]phosphonic acid
C10H14N5O7P (347.06308240000004)
1-(3,4-Dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)urea
N-{5-chloro-2-nitrobenzylidene}-4-ethoxybenzohydrazide
4-chloro-N-(4-imidazo[1,2-a]pyridin-2-ylphenyl)benzamide
C20H14ClN3O (347.08253440000004)
4-Amino-5,8-dimethoxy-2-(1,1,2,2,2-pentafluoroethyl)-3-quinolinecarbonitrile
Acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester
C17H17NO5S (347.08273920000005)
N-[[(6-methyl-2-pyridinyl)amino]-sulfanylidenemethyl]-4-phenylbenzamide
[2-(Methylthio)phenyl]-[1-[oxo(4-thiadiazolyl)methyl]-3-piperidinyl]methanone
(1-Methyl-3-indolyl)-diphenyl-sulfanylidenephosphorane
C21H18NPS (347.08975180000004)
1-[4-(3,5-Dimethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide
C17H21N3O3S (347.13035560000003)
1-(2-Chloro-4-nitrophenyl)-4-(2-methoxyphenyl)piperazine
C17H18ClN3O3 (347.10366280000005)
N-(1,1-dioxo-2,3-dihydrothiophen-3-yl)-N-(2-ethylphenyl)-2-thiophenecarboxamide
1-(3-Methoxyphenyl)-3-[5-(2-methyl-1-piperidinyl)-1,3,4-thiadiazol-2-yl]urea
C16H21N5O2S (347.14158860000003)
N-[(R)-[(1R,2R)-2-butylcyclopropyl]-(4-chlorophenyl)methyl]-2-thiophenecarboxamide
C19H22ClNOS (347.11105520000007)
6-(3-methoxyphenyl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine
3-[[[3-(4-Methoxyphenyl)phenyl]-oxomethyl]amino]benzoic acid
C21H17NO4 (347.11575220000003)
6-Amino-5-cyano-2-phenyl-4-pyridin-4-yl-4H-pyran-3-carboxylic acid ethyl ester
C20H17N3O3 (347.12698520000004)
1-[[(4-Ethyl-5-methyl-3-thiophenyl)-oxomethyl]amino]-3-(2-phenylethyl)thiourea
N-[4-(4-acetyl-1-piperazinyl)-3-chlorophenyl]-2-furancarboxamide
C17H18ClN3O3 (347.10366280000005)
N-(2,5-dimethoxyphenyl)-4-(2,4-dimethyl-5-thiazolyl)-2-thiazolamine
2-Chloro-5-[[2,3-dihydro-1,4-benzodioxin-3-yl(oxo)methyl]amino]benzoic acid methyl ester
6-(2-Furanyl)-3-methyl-1-phenyl-4-pyrazolo[3,4-b]pyridinecarboxylic acid ethyl ester
C20H17N3O3 (347.12698520000004)
6-Chloro-4-[[(2-fluorophenyl)methyl-methylamino]methyl]-7-hydroxy-1-benzopyran-2-one
C18H15ClFNO3 (347.07244420000006)
[2-(Methylamino)-2-oxoethyl] 1-(4-fluorophenyl)-3-methylthieno[2,3-c]pyrazole-5-carboxylate
3-(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)-N-(3-fluoro-4-methylphenyl)propanamide
5-[[3-Methyl-1-(4-methylphenyl)-5-oxo-4-pyrazolylidene]methylamino]-1,3-dihydrobenzimidazol-2-one
N-(5-chloro-2-methoxyphenyl)-2-pyridin-4-yl-4,5-dihydrothiazole-4-carboxamide
N-[(4-tert-butylcyclohexylidene)amino]-3-chloro-5-(trifluoromethyl)-2-pyridinamine
N-[1-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)ethyl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)urea
3-(6-Methylpyridin-2-yl)-2-(4-pyridin-3-ylphenyl)-1,3-thiazolidin-4-one
Met-FMDP
A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-methionine joined by peptide linkages.
2-amino-9-(2-deoxy-5-O-phosphono-beta-L-erythro-pentofuranosyl)-1,9-dihydro-6H-purin-6-one
C10H14N5O7P (347.06308240000004)
N-[3-(dimethylamino)propyl]-N-(4-fluoro-1,3-benzothiazol-2-yl)-2-furancarboxamide
C17H18FN3O2S (347.11037000000005)
2-[2-Fluoro-4-chloro-5-[(S)-1-methyl-2-propynyloxy]phenyl]-4,5,6,7-tetrahydro-2H-isoindole-1,3-dione
C18H15ClFNO3 (347.07244420000006)
2-[2-Fluoro-4-chloro-5-[(R)-1-methyl-2-propynyloxy]phenyl]-4,5,6,7-tetrahydro-2H-isoindole-1,3-dione
C18H15ClFNO3 (347.07244420000006)
8-Amino-9-benzoyl-5-oxa-7-thia-cyclohepta[a]naphthalen-6-one
C20H13NO3S (347.06161080000004)
3-[(2,5-Dimethoxyphenyl)iminomethyl]-1,5-dioxaspiro[5.5]undecane-2,4-dione
C18H21NO6 (347.13688060000004)
5-[(E)-[[7-(hydroxyamino)-7-oxoheptanoyl]hydrazinylidene]methyl]furan-2-sulfonic acid
2-[1-(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)ethyl]-N-phenylhydrazinecarbothioamide
2 inverted exclamation marka-Deoxy-N-(2-furanylmethyl)guanosine
[(2S,3R,4R,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
C10H14N5O7P (347.06308240000004)
dicyanide
C20H13NO5 (347.07936880000005)
Hydroxysanguinarine is a benzophenanthridine alkaloid. Hydroxysanguinarine is a natural product found in Fumaria indica, Fumaria parviflora, and other organisms with data available.
Adenosine phosphate
C10H14N5O7P (347.06308240000004)
A purine ribonucleoside 5-monophosphate having adenine as the nucleobase. COVID info from PDB, Protein Data Bank, COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction.
7-(5-phospho-alpha-D-ribosyl)adenine
C10H14N5O7P (347.06308240000004)
5-Aminofluorescein
C20H13NO5 (347.07936880000005)
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
(2R)-1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
1-naphthyl N-acetyl-beta-D-glucosaminide
C18H21NO6 (347.13688060000004)
An N-acetyl-beta-D-glucosaminide in which the anomeric hydroxy hydrogen is replaced by a 1-naphthyl group.
8-oxo-dAMP
C10H14N5O7P (347.06308240000004)
A purine 2-deoxyribonucleoside 5-diphosphate that is the 8-oxo derivative of dADP.
3-AMP
C10H14N5O7P (347.06308240000004)
An adenosine 3-phosphate with a monophosphate group at the 3-position.
5-carboxymethylaminomethyl-2-thiouridine
A thiouridine that is 2-thiouridine bearing an additional carboxymethylaminomethyl substituent at position 5 on the thiouracil ring.
2-hydroxy-7-methoxy-10,13-dimethyl-9,18-dioxo-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1(19),3(8),4,6,12,14,16-heptaen-10-ium-11-ide
C21H17NO4 (347.11575220000003)
7-hydroxy-19-[(1s)-1-hydroxyethyl]-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
C20H17N3O3 (347.12698520000004)
methyl (2s)-2-hydroxy-3,3-dimethoxy-4-methyl-1,9-dioxocyclopenta[b]quinoline-2-carboxylate
(1s,13s,15r,16s,18r,19r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol
C18H21NO6 (347.13688060000004)
(2r)-1-({4,7-dimethoxyfuro[2,3-b]quinolin-6-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
methyl 2-hydroxy-3-{4-[5-hydroxy-4-(2-methylpropyl)-2-oxopyrrol-3-yl]phenoxy}propanoate
C18H21NO6 (347.13688060000004)
9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2(10),3,8-trien-11-ol
C18H21NO6 (347.13688060000004)
(2s)-1-({7,8-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
(1s)-21-methyl-14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-12-carboxylic acid
C20H17N3O3 (347.12698520000004)
9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol
C18H21NO6 (347.13688060000004)
15-hydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one
C18H21NO6 (347.13688060000004)
(1r,5's,6'r,7'ar)-5',6'-dihydroxy-5,6-dimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one
C18H21NO6 (347.13688060000004)
(2s,3s,6r,12r)-3,12-dihydroxy-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-10-ium-10-olate
C18H21NO6 (347.13688060000004)
1-({7,8-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-diene-3,8,15-trione
C18H21NO6 (347.13688060000004)
11-β-hydroxycephalotaxine β-n-oxide
C18H21NO6 (347.13688060000004)
{"Ingredient_id": "HBIN000367","Ingredient_name": "11-\u03b2-hydroxycephalotaxine \u03b2-n-oxide","Alias": "NA","Ingredient_formula": "C18H21NO6","Ingredient_Smile": "COC1=CC23CCC[N+]2(CC(C4=CC5=C(C=C4C3C1O)OCO5)O)[O-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9901","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-carboxyevodiamine
C20H17N3O3 (347.12698520000004)
{"Ingredient_id": "HBIN013133","Ingredient_name": "7-carboxyevodiamine","Alias": "NA","Ingredient_formula": "C20H17N3O3","Ingredient_Smile": "NA","Ingredient_weight": "347.37","OB_score": "NA","CAS_id": "69754-32-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7462;19315","PubChem_id": "NA","DrugBank_id": "NA"}
Aporphin
C19H22ClNO3 (347.1288132000001)
{"Ingredient_id": "HBIN016514","Ingredient_name": "Aporphin","Alias": "NA","Ingredient_formula": "C19H22ClNO3","Ingredient_Smile": "C[NH+]1CCC2=CC(=C(C3=C2C1CC4=C3C(=CC=C4)OC)O)OC.[Cl-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32984","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
9-hydroxy-7,9-dimethoxy-13-methyl-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one
C21H17NO4 (347.11575220000003)
11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one
C20H17N3O3 (347.12698520000004)
(1s,13r,15r,16s,18r,19r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol
C18H21NO6 (347.13688060000004)
(2r)-1-({4,6-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
(3as)-6,8-dihydroxy-1-(1h-indol-3-yl)-3ah,4h-naphtho[2,1-b]furan-2,5-dione
C20H13NO5 (347.07936880000005)
(2s)-1-({6,7-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
(3s,4s)-4-(5,7-dihydroxy-2-methyl-4-oxochromen-8-yl)-1-methylpiperidin-3-yl acetate
C18H21NO6 (347.13688060000004)
(3s,4'r)-2-hydroxy-4'-(4-oxoquinazolin-3-yl)spiro[indole-3,2'-oxolan]-5'-one
C19H13N3O4 (347.09060180000006)
(1s,4z,6s,7r)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-diene-3,8,15-trione
C18H21NO6 (347.13688060000004)
(7r)-7-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
C16H17N3O4S (347.09397220000005)
(1s,2s,6r,8s,9r,10s)-15-hydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one
C18H21NO6 (347.13688060000004)
(6r,7r)-7-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
C16H17N3O4S (347.09397220000005)
1-({6,7-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
6,8-dihydroxy-1-(1h-indol-3-yl)-3ah,4h-naphtho[2,1-b]furan-2,5-dione
C20H13NO5 (347.07936880000005)
(2s)-2-[(1r)-6-bromo-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]-1-methylpyrrolidine
C17H22BrN3 (347.09969920000003)
17,18-dimethoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
C20H17N3O3 (347.12698520000004)
(2s)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
(3r,6r)-6-(1h-indol-3-ylmethyl)-3-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol
C17H21N3O3S (347.13035560000003)
(2s,3s,6r,10r,12r)-3,12-dihydroxy-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-10-ium-10-olate
C18H21NO6 (347.13688060000004)
(2r)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
(1r,13s,16s,17r)-13,17-dihydroxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-16-yl acetate
C18H21NO6 (347.13688060000004)
7-[(4-chloro-3-methylbut-2-en-1-yl)oxy]-4,8-dimethoxyfuro[2,3-b]quinoline
C18H18ClNO4 (347.09242980000005)
(3r,6r)-3-(1h-indol-3-ylmethyl)-6-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol
C17H21N3O3S (347.13035560000003)
(7s,8s)-11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one
C20H17N3O3 (347.12698520000004)
18-methoxy-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16,18,20-heptaene-7,15-dione
C20H17N3O3 (347.12698520000004)
3-(1h-indol-3-ylmethyl)-6-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol
C17H21N3O3S (347.13035560000003)
[3-hydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxyphosphonic acid
C10H14N5O7P (347.06308240000004)
(4r,5r,7e,9s,11r)-3,5,14-trihydroxy-4-methyl-17-oxa-2-azatricyclo[7.6.2.0¹²,¹⁶]heptadeca-1(15),2,7,12(16),13-pentaen-11-yl acetate
C18H21NO6 (347.13688060000004)
(2r,3r,4s,5r)-2-{6-[(furan-2-ylmethyl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol
19-methoxy-3,5-dioxa-11-azahexacyclo[9.9.2.0²,⁶.0⁸,²¹.0¹⁴,²².0¹⁵,²⁰]docosa-1(21),2(6),7,14(22),15(20),16,18-heptaene-12,13-dione
C20H13NO5 (347.07936880000005)
23-methoxy-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2(10),3,8,11,14(22),15,17(21),23-nonaene
C20H13NO5 (347.07936880000005)
methyl 4-{6-methoxy-9-methyl-8-oxo-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-2-methylbutanoate
C18H21NO6 (347.13688060000004)
11-methoxy-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2(10),3,8,11,14(22),15,20,23-nonaene
C20H13NO5 (347.07936880000005)
methyl 2-hydroxy-3,3-dimethoxy-4-methyl-1,9-dioxocyclopenta[b]quinoline-2-carboxylate
1-({4,6-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
n-(2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)ethanimidic acid
C20H17N3O3 (347.12698520000004)
(11s,12r)-11-ethoxy-12-hydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
C20H17N3O3 (347.12698520000004)
7-hydroxy-19-(1-hydroxyethyl)-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
C20H17N3O3 (347.12698520000004)
12-methyl-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2(10),3,8,14(22),15,20,23-octaen-11-one
C20H13NO5 (347.07936880000005)
6-(1h-indol-3-ylmethyl)-3-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol
C17H21N3O3S (347.13035560000003)
n-[(2r)-2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl]ethanimidic acid
C20H17N3O3 (347.12698520000004)
(2s)-1-({4,7-dimethoxyfuro[2,3-b]quinolin-6-yl}oxy)-3-methylbutane-2,3-diol
C18H21NO6 (347.13688060000004)
(1r,4z,6r,7r)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-diene-3,8,15-trione
C18H21NO6 (347.13688060000004)
2-hydroxy-4'-(4-oxoquinazolin-3-yl)spiro[indole-3,2'-oxolan]-5'-one
C19H13N3O4 (347.09060180000006)
7-{[(2e)-4-chloro-3-methylbut-2-en-1-yl]oxy}-4,8-dimethoxyfuro[2,3-b]quinoline
C18H18ClNO4 (347.09242980000005)
methyl (2r)-4-{6-methoxy-9-methyl-8-oxo-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-2-methylbutanoate
C18H21NO6 (347.13688060000004)
(1s,11r,13r,15r,16s,18r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2(10),3,8-trien-11-ol
C18H21NO6 (347.13688060000004)